Menu
← Oncology Approval Tracker
FDA DECISION ·
Hepzato Kit
melphalan for injection with hepatic delivery system · Delcath Systems
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Liver-directed therapy for adults with uveal melanoma and unresectable metastases occupying less than 50% of the liver. Extrahepatic disease must be absent or limited to bone, lymph nodes, subcutaneous tissues, or lung and amenable to resection or radiation.
LAMPGEN ANALYSIS
Why it matters
The drug-device combination added a regional treatment for a defined liver-metastatic uveal melanoma population.
What research teams should watch
Document hepatic tumor burden and extrahepatic sites, and coordinate qualified procedural teams and safety oversight.
Related study operations checklist
See the staffing responsibilities, timing, and handoff questions for this study setting.
Liver-directed metastatic uveal melanomaPRIMARY RECORDS